Avanzanite Bioscience seeks to commercialize innovative drugs for rare diseases in Europe
Avazanite Bioscience BV has officially launched its business to commercial stage, to expand patient access to rare disease medicines in Europe while unlocking revenue and growth potential for emerging research-based biopharmaceutical creators. Avazanite, a fully licensed distributor of medicines, partners with biopharmaceutical collaborators through flexible, tailored licensing and distribution partnerships across Europe. The company’s business …